Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome

A. B. Pawlowska, S. M. Davies, P. J. Orchard, J. E. Wagner, N. K.C. Ramsay

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The incidence of hematologic disorders in patients with Down's syndrome (DS) is significantly increased, and includes neonatal transient abnormal myelopoiesis and acute leukemias. Treatment of children with DS and leukemia has been controversial because of toxicity and associated congenital cardiac and other abnormalities. The role of BMT, particularly from an unrelated donor (URD), remains undefined in this population. We report two children with DS and acute leukemia successfully treated with intensive chemotherapy and matched URD bone marrow transplantation. One child was transplanted in third remission of ALL and has been disease free for 8 months. A second child with AML was transplanted in second remission and is disease free 15 months post-BMT.

Original languageEnglish (US)
Pages (from-to)453-455
Number of pages3
JournalBone marrow transplantation
Volume18
Issue number2
StatePublished - Aug 1996

Keywords

  • BMT
  • Down's syndrome
  • Unrelated donor

Fingerprint Dive into the research topics of 'Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome'. Together they form a unique fingerprint.

Cite this